Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clearance of Driver Mutations after Transplantation for Myelofibrosis.
Gagelmann N, Quarder M, Badbaran A, Rathje K, Janson D, Lück C, Richter J, Marquard F, Oechsler S, Massoud R, Klyuchnikov E, Rudolph I, Schäfersküpper M, Niederwieser C, Heidenreich S, Berger C, Fehse B, Wolschke C, Ayuk F, Kröger N. Gagelmann N, et al. Among authors: badbaran a. N Engl J Med. 2025 Jan 9;392(2):150-160. doi: 10.1056/NEJMoa2408941. N Engl J Med. 2025. PMID: 39778169
Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis.
Christopeit M, Badbaran A, Zabelina T, Zeck G, Fehse B, Ayuk F, Wolschke C, Kröger N. Christopeit M, et al. Among authors: badbaran a. Bone Marrow Transplant. 2016 Oct;51(10):1391-1393. doi: 10.1038/bmt.2016.128. Epub 2016 May 23. Bone Marrow Transplant. 2016. PMID: 27214077 No abstract available.
Impact of molecular residual disease post allografting in myelofibrosis patients.
Wolschke C, Badbaran A, Zabelina T, Christopeit M, Ayuk F, Triviai I, Zander A, Alchalby H, Bacher U, Fehse B, Kröger N. Wolschke C, et al. Among authors: badbaran a. Bone Marrow Transplant. 2017 Nov;52(11):1526-1529. doi: 10.1038/bmt.2017.157. Epub 2017 Jul 17. Bone Marrow Transplant. 2017. PMID: 28714945
Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation.
Kröger N, Shahnaz Syed Abd Kadir S, Zabelina T, Badbaran A, Christopeit M, Ayuk F, Wolschke C. Kröger N, et al. Among authors: badbaran a. Biol Blood Marrow Transplant. 2018 Oct;24(10):2152-2156. doi: 10.1016/j.bbmt.2018.05.023. Epub 2018 May 22. Biol Blood Marrow Transplant. 2018. PMID: 29800615 Free article.
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis.
Mannina D, Badbaran A, Wolschke C, Klyuchnikov E, Christopeit M, Fehse B, Kröger N. Mannina D, et al. Among authors: badbaran a. Bone Marrow Transplant. 2022 Mar;57(3):510-512. doi: 10.1038/s41409-022-01566-0. Epub 2022 Jan 19. Bone Marrow Transplant. 2022. PMID: 35046544 Free PMC article. No abstract available.
65 results